Dachaigh › Atharocslerosis › Tennessee
Sgrùdaidhean clionaigeach Atharocslerosis ann an Tennessee
Tha 9 sgrùdaidhean airson Atharocslerosis a’ lorg phàirtichean aig làraichean ann an Tennessee.
Bailtean ann an Tennessee
Teacsa sgrùdaidh oifigeil (Beurla)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Stern Cardiovascular Foundation Inc, Germantown
- Accellacare of Knoxville, Knoxville
- Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 45 gu 99 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07037433A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Vanderbilt University School of Medicine (VUSM) - Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Nashville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07448038Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
- St. Jude Children's Research Hospital, Memphis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07594392Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- WR-Clinsearch, LLC, Chattanooga
- Erlanger Health System, Chattanooga
- The Jackson Clinic, Jackson
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- agus 2 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Chattanooga
- Research Site, Chattanooga
- Research Site, Greeneville
- agus 9 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Novartis Investigative Site, Tullahoma
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Apex Cardiology Research Associates of Jackson, Jackson
A’ fastadhÌre 3
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT02915198Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.